MedPath

Carisoprodol

Carisoprodol

Approved
Approval ID

ead8294f-fd27-5c3d-e053-2a95a90a64af

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 9, 2022

Manufacturers
FDA

Direct_Rx

DUNS: 079254320

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Carisoprodol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72189-386
Application NumberANDA040792
Product Classification
M
Marketing Category
C73584
G
Generic Name
Carisoprodol
Product Specifications
Route of AdministrationORAL
Effective DateNovember 9, 2022
FDA Product Classification

INGREDIENTS (7)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CARISOPRODOLActive
Quantity: 350 mg in 1 1
Code: 21925K482H
Classification: ACTIB
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MK
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Carisoprodol - FDA Drug Approval Details